{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:23:57Z","timestamp":1791260637234,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX002741"],"award-info":[{"award-number":["BX002741"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM135258"],"award-info":[{"award-number":["GM135258"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM093854"],"award-info":[{"award-number":["GM093854"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014620","name":"Micropalaeontological Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES007148"],"award-info":[{"award-number":["ES007148"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES029258"],"award-info":[{"award-number":["ES029258"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK122725"],"award-info":[{"award-number":["DK122725"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.dmd.2025.100222","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T16:16:12Z","timestamp":1766420172000},"page":"100222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mutation of PXR phosphorylation motif at Ser347 disrupts lipid and bile acid homeostasis in diet-induced metabolic dysfunction\u2013associated steatohepatitis in mice"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1830-4809","authenticated-orcid":false,"given":"Veronia","family":"Basaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6272-8115","authenticated-orcid":false,"given":"Zakiyah R.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0561-3653","authenticated-orcid":false,"given":"Rulaiha E.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8200-7817","authenticated-orcid":false,"given":"Bo","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ill","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3483-0235","authenticated-orcid":false,"given":"Anita","family":"Brinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie B.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0032-1037","authenticated-orcid":false,"given":"Lauren","family":"Aleksunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Negishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-0635","authenticated-orcid":false,"given":"Grace L.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.dmd.2025.100222_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cld.1061","article-title":"Global epidemiology of chronic liver disease","volume":"17","author":"Cheemerla","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"9","key":"10.1016\/j.dmd.2025.100222_bib2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"suppl","key":"10.1016\/j.dmd.2025.100222_bib3","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"7","key":"10.1016\/j.dmd.2025.100222_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.dmd.2025.100222_bib5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \"hits\"?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.dmd.2025.100222_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/cells11010061","article-title":"The nuclear receptor PXR in chronic liver disease","volume":"11","author":"Sayaf","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.dmd.2025.100222_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/mol.117.110155","article-title":"PXR: more than just a master xenobiotic receptor","volume":"93","author":"Oladimeji","year":"2018","journal-title":"Mol Pharmacol"},{"issue":"21","key":"10.1016\/j.dmd.2025.100222_bib8","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1074\/jbc.M511116200","article-title":"A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway","volume":"281","author":"Zhou","year":"2006","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.dmd.2025.100222_bib9","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1124\/mol.114.097287","article-title":"SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver","volume":"87","author":"Li","year":"2015","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100222_bib10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2007.11.037","article-title":"Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis","volume":"134","author":"Zhou","year":"2008","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.dmd.2025.100222_bib11","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1128\/MCB.24.18.7931-7940.2004","article-title":"Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes","volume":"24","author":"Kodama","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100222_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/BJ20070481","article-title":"Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene","volume":"407","author":"Kodama","year":"2007","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.dmd.2025.100222_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2133\/dmpk.23.8","article-title":"The roles of nuclear receptors CAR and PXR in hepatic energy metabolism","volume":"23","author":"Konno","year":"2008","journal-title":"Drug Metab Pharmacokinet"},{"issue":"2","key":"10.1016\/j.dmd.2025.100222_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.molpha.2024.100014","article-title":"Insights of direct and indirect regulation of PXR through phosphorylation in fatty liver disease","volume":"107","author":"Basaly","year":"2025","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100222_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bcp.2015.06.018","article-title":"Serine 350 of human pregnane X receptor is crucial for its heterodimerization with retinoid X receptor alpha and transactivation of target genes in vitro and in vivo","volume":"96","author":"Wang","year":"2015","journal-title":"Biochem Pharmacol"},{"issue":"45","key":"10.1016\/j.dmd.2025.100222_bib16","doi-asserted-by":"crossref","first-page":"30650","DOI":"10.1074\/jbc.M806132200","article-title":"Cyclin-dependent kinase 2 negatively regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells","volume":"283","author":"Lin","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dmd.2025.100222_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cellsig.2017.09.003","article-title":"Glucose elicits serine\/threonine kinase VRK1 to phosphorylate nuclear pregnane X receptor as a novel hepatic gluconeogenic signal","volume":"40","author":"Gotoh","year":"2017","journal-title":"Cell Signal"},{"key":"10.1016\/j.dmd.2025.100222_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbrc.2022.05.055","article-title":"Mice blocking Ser347 phosphorylation of pregnane x receptor develop hepatic fasting-induced steatosis and hypertriglyceridemia","volume":"615","author":"Yokobori","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.dmd.2025.100222_bib19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/toxsci\/kfae029","article-title":"Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse model","volume":"199","author":"Taylor","year":"2024","journal-title":"Toxicol Sci"},{"issue":"4","key":"10.1016\/j.dmd.2025.100222_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4254\/wjh.v13.i4.433","article-title":"Bile acid indices as biomarkers for liver diseases I: diagnostic markers","volume":"13","author":"Alamoudi","year":"2021","journal-title":"World J Hepatol"},{"issue":"9","key":"10.1016\/j.dmd.2025.100222_bib21","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3390\/biom13091356","article-title":"Alterations in circulating bile acids in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis","volume":"13","author":"Lai","year":"2023","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.dmd.2025.100222_bib22","doi-asserted-by":"crossref","first-page":"E1195","DOI":"10.1152\/ajpendo.00513.2004","article-title":"PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes","volume":"288","author":"Schadinger","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.dmd.2025.100222_bib23","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2010.222844","article-title":"Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C","volume":"60","author":"Miquilena-Colina","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.dmd.2025.100222_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101428","article-title":"CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing","volume":"57","author":"Zeng","year":"2022","journal-title":"Mol Metab"},{"issue":"4","key":"10.1016\/j.dmd.2025.100222_bib25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cmet.2008.03.003","article-title":"Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27","volume":"7","author":"Matsusue","year":"2008","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.dmd.2025.100222_bib26","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jhep.2016.05.041","article-title":"Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2","volume":"65","author":"Ye","year":"2016","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100222_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3350\/cmh.2020.0261","article-title":"Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis","volume":"27","author":"Xu","year":"2021","journal-title":"Clin Mol Hepatol"},{"issue":"22","key":"10.1016\/j.dmd.2025.100222_bib28","doi-asserted-by":"crossref","first-page":"7943","DOI":"10.1093\/nar\/gkq654","article-title":"ChIPing the cistrome of PXR in mouse liver","volume":"38","author":"Cui","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.dmd.2025.100222_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/cdn\/nzab138","article-title":"Considerations when choosing high-fat, high-fructose, and high-cholesterol diets to induce experimental nonalcoholic fatty liver disease in laboratory animal models","volume":"5","author":"Radhakrishnan","year":"2021","journal-title":"Curr Dev Nutr"},{"issue":"1","key":"10.1016\/j.dmd.2025.100222_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1755-1536-6-18","article-title":"The role of mouse strain differences in the susceptibility to fibrosis: a systematic review","volume":"6","author":"Walkin","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"1","key":"10.1016\/j.dmd.2025.100222_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"10.1016\/j.dmd.2025.100222_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"issue":"12","key":"10.1016\/j.dmd.2025.100222_bib33","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","article-title":"Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine","volume":"48","author":"Kim","year":"2007","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.dmd.2025.100222_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/03602532.2012.740048","article-title":"Nuclear receptors in bile acid metabolism","volume":"45","author":"Li","year":"2013","journal-title":"Drug Metab Rev"},{"issue":"31","key":"10.1016\/j.dmd.2025.100222_bib35","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.3748\/wjg.v13.i31.4230","article-title":"Lithocholic acid induction of the FGF19 promoter in intestinal cells is mediated by PXR","volume":"13","author":"Wistuba","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.dmd.2025.100222_bib36","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1053\/j.gastro.2011.02.055","article-title":"PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts","volume":"140","author":"He","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dmd.2025.100222_bib37","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bcp.2017.07.019","article-title":"Pregnane X receptor (PXR) deficiency improves high fat diet-induced obesity via induction of fibroblast growth factor 15 (FGF15) expression","volume":"142","author":"Zhao","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"22","key":"10.1016\/j.dmd.2025.100222_bib38","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202401630R","article-title":"Integrative analysis of non12-hydroxylated bile acid revealed the suppressed molecular map of alternative pathway in nonalcoholic steatohepatitis mice","volume":"38","author":"Feng","year":"2024","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.dmd.2025.100222_bib39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13238-020-00804-9","article-title":"Targeting the alternative bile acid synthetic pathway for metabolic diseases","volume":"12","author":"Jia","year":"2021","journal-title":"Protein Cell"},{"issue":"3","key":"10.1016\/j.dmd.2025.100222_bib40","doi-asserted-by":"crossref","first-page":"G494","DOI":"10.1152\/ajpgi.00156.2003","article-title":"Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse","volume":"285","author":"Wang","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.dmd.2025.100222_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111812","article-title":"Elevated expression of LCN13 through FXR activation ameliorates hepatocellular lipid accumulation and inflammation","volume":"131","author":"Qin","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100222_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhep.2024.09.032","article-title":"Bile acid metabolism and signalling in liver disease","volume":"82","author":"Fuchs","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.dmd.2025.100222_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114664","article-title":"Altered bile acid composition and disposition in a mouse model of non-alcoholic steatohepatitis","volume":"379","author":"Suga","year":"2019","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100222_bib44","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.29359","article-title":"The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.dmd.2025.100222_bib45","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1007\/s10620-015-3776-8","article-title":"Altered bile acid metabolome in patients with nonalcoholic steatohepatitis","volume":"60","author":"Ferslew","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dmd.2025.100222_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108412","article-title":"Association between 12\u03b1-hydroxylated bile acids and hepatic steatosis in rats fed a high-fat diet","volume":"83","author":"Hori","year":"2020","journal-title":"J Nutr Biochem"},{"issue":"12","key":"10.1016\/j.dmd.2025.100222_bib47","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.2337\/db13-0639","article-title":"Human insulin resistance is associated with increased plasma levels of 12\u03b1-hydroxylated bile acids","volume":"62","author":"Haeusler","year":"2013","journal-title":"Diabetes"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625095315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625095315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:51:39Z","timestamp":1773982299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625095315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0090955625095315"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100222","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutation of PXR phosphorylation motif at Ser347 disrupts lipid and bile acid homeostasis in diet-induced metabolic dysfunction\u2013associated steatohepatitis in mice","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100222"}}